• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Layoffs
Biotech

Pressure of biopharma layoffs continues to ease in Q2'26

A sharp reduction in layoffs continued in the second quarter, extending a trend that started last fall, an analysis of Fierce data has revealed.
Will Maddox Jul 1, 2026 10:30am
AZ

AstraZeneca pays CSPC $30M to form kidney drug discovery pact

Jul 3, 2026 8:00am
Glowing puzzle piece fitting into puzzle

United Therapeutics pays $140M for thymic cell therapy startup

Jul 3, 2026 5:49am
Graphic of two hands shaking under a red and purple light

Fosun pays $32M to join Lilly and Novartis in psoriasis market

Jul 2, 2026 8:30am
raised boxing glove with confetti falling around it

Roche orchestrates phase 3 lung cancer win over Amgen and BMS

Jul 2, 2026 8:30am
Takeda lungs ESMO 2023

Insilico inks partnership via $600M biobuck collab with Takeda

Jul 1, 2026 8:30pm
More News

Merck halts ph. 2 Alzheimer’s trial after underwhelming efficacy

Jul 1, 2026 2:35pm

Ipsen pens €700M deal to buy Swiss biotech for rare disease drug

Jul 1, 2026 8:05am

Backed by top VCs, biotech bags Alzheimer’s med in $2.2B deal

Jul 1, 2026 4:40am

Bain-backed Angitia drops lead spinal fusion candidate

Jun 30, 2026 4:56pm
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings